Influence of Luteolin for Two Weeks on Memory in Healthy Subjects
NCT06047899 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 44
Last updated 2024-05-09
Summary
The goal of this clinical trial is to learn about the effect of the dietary supplement luteolin in healthy people. The main question it aims to answer is: Does luteolin have an influence on memory functions?
Participants will go trough two treatment phases. In one phase they will take 250mg luteolin twice daily for two weeks. In the other phase they will take a placebo twice daily for two weeks. A placebo is a look-alike substance that contains no active drug.
At the start and end of teach treatment phase, participants will undergo different memory testing exercises in our research facility.
Conditions
- Memory
Interventions
- DIETARY_SUPPLEMENT
-
Luteolin
Luteolin extracted from Chrysanthemum Ramat 98% HPLC by Scyherb® food grade certified according to Safe Quality Foods (SQF) - Level 3 Comprehensive Food Safety and Quality Management System Certification by the Safe Quality Food Institute (SQFI).
- OTHER
-
Placebo
mannitol formulated for oral administration (capsules)
Sponsors & Collaborators
-
Prof. Dominique de Quervain, MD
lead OTHER
Principal Investigators
-
Dominique de Quervain, Prof · University of Basel
-
Christiane Gerhards, MD · University of Basel
Study Design
- Allocation
- RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- QUADRUPLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Max Age
- 40 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2023-11-28
- Primary Completion
- 2024-05-02
- Completion
- 2024-05-02
Countries
- Switzerland
Study Locations
More Related Trials
-
Effects of Donepezil and Memantine on Cognitive Functions After a Sleep Deprivation Challenge in Healthy Volunteers
NCT01461174 ·Status: COMPLETED ·Phase: PHASE1
-
Reducing the Effects of Aging on Cognition With Therapeutic Intervention of an Oral Nutrient (REACTION): A Pilot Trial
NCT04147624 ·Status: COMPLETED ·Phase: PHASE2
-
The Memory and Cognitive Performance Study
NCT04025255 ·Status: COMPLETED ·Phase: NA
-
Pilot Study of the Effects of Resveratrol Supplement in Mild-to-moderate Alzheimer's Disease
NCT00743743 ·Status: WITHDRAWN ·Phase: PHASE3
-
B-vitamins Treatment for Improvement of Cognitive Function
NCT01095211 ·Status: COMPLETED ·Phase: NA
-
Influence of Losartan and Diphenhydramine on Emotional and Cognitive Functions in Healthy Human Subjects
NCT01321021 ·Status: COMPLETED ·Phase: NA
-
A Clinical Trial Investigating the Efficacy and Safety of a Lipase Thera-blend and a Lipase Thera-blend + Tributyrin on Memory in Healthy Adults With Self-reported Memory Problems
NCT07020494 ·Status: COMPLETED ·Phase: NA
-
Multicenter Evaluation of Memory Remediation After TBI With Donepezil
NCT02255799 ·Status: COMPLETED ·Phase: PHASE3
-
Prediction of Cognitive Properties of Memantine for Neurodegenerative Diseases
NCT02288000 ·Status: TERMINATED ·Phase: PHASE1
-
The Impact of Lorazepam on Cognition in APOE e4 Carriers
NCT00586430 ·Status: COMPLETED ·Phase: NA
-
18-Month Study of Memory Effects of Curcumin
NCT01383161 ·Status: COMPLETED ·Phase: PHASE2
-
To Evaluate Effects of AZD1446, Placebo and Donepezil in Patients With Alzheimer's Disease
NCT01125683 ·Status: TERMINATED ·Phase: PHASE2
-
MLC901 in Moderate Traumatic Brain Injury
NCT04766281 ·Status: UNKNOWN ·Phase: PHASE4
-
Cognitive Effects of Roflumilast in (a)MCI and Mild Dementia Patients
NCT04658654 ·Status: UNKNOWN ·Phase: PHASE2
-
Evaluation of the Effects of a Nutritional Intervention of Ketogenic Medium-chain Triglycerides and B-vitamins on Cognitive Functioning in Older Adults With Mild Cognitive Impairment (COGNIKET-MCI)
NCT06347315 ·Status: RECRUITING ·Phase: NA
-
A Study Of PF-04447943 Compared To Placebo In Subjects With Mild To Moderate Alzheimer's Disease
NCT00930059 ·Status: COMPLETED ·Phase: PHASE2
-
Healthy Adults With Mild Cognitive Impairment (MCI) and a 16-week Intervention With Mitocholine™, a Functional Food Ingredient
NCT05690724 ·Status: RECRUITING ·Phase: NA
-
Study With Lu AF87908 in Healthy Participants and Participants With Alzheimer's Disease
NCT04149860 ·Status: COMPLETED ·Phase: PHASE1
-
Anti-Oxidant Treatment of Alzheimer's Disease
NCT00117403 ·Status: COMPLETED ·Phase: PHASE1
-
The Cognitive Effects of Lorazepam in Healthy Older Individuals With TOMM40 Variable-length Polymorphisms
NCT01780519 ·Status: COMPLETED ·Phase: PHASE1
-
Study of TAK-071 in Healthy Participants and Participants With Mild Cognitive Impairment/Mild Alzheimer Disease and Relative Bioavailability (BA) and Food Effect of TAK-071 in Healthy Participants
NCT02769065 ·Status: TERMINATED ·Phase: PHASE1
-
Levetiracetam and Memory Function in Amnestic Mild Cognitive Impairment (MCI)
NCT01044758 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of BCI-838 and Several BCI-632 Prodrugs in Healthy Volunteers
NCT01546051 ·Status: COMPLETED ·Phase: PHASE1
-
Effects of a Food Supplement on Cognitive and Neuropsychological Functioning in Older Adults.
NCT03145987 ·Status: COMPLETED ·Phase: NA
-
Effects of Nicotinamide Riboside on Bioenergetics and Oxidative Stress in Mild Cognitive Impairment/Alzheimer's Dementia
NCT04430517 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1